Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
51
SNY Quote, Financials, Valuation and Earnings
Last price:
$48.89
Seasonality move
:
1.11%
Day range:
$49.59 - $49.91
52-week range:
$44.62 - $60.12
Dividend yield:
4.42%
P/E ratio:
12.41x
P/S ratio:
2.86x
P/B ratio:
1.76x
Volume:
4.5M
Avg. volume:
2.4M
1-year change:
3.16%
Market cap:
$121.2B
Revenue:
$44.4B
EPS (TTM):
$4.02
Analysts' Opinion
-
Consensus RatingSanofi has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $60.13, Sanofi has an estimated upside of 21.01% from its current price of $49.69.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $56.00 representing -12.7% downside risk from its current price of $49.69.
Fair Value
-
According to the consensus of 7 analysts, Sanofi has 21.01% upside to fair value with a price target of $60.13 per share.
SNY vs. S&P 500
-
Over the past 5 trading days, Sanofi has underperformed the S&P 500 by -1.18% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sanofi does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sanofi has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Sanofi reported revenues of $12.2B.
Earnings Growth
-
Sanofi has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Sanofi reported earnings per share of $1.83.
Enterprise value:
127.6B
EV / Invested capital:
--
Price / LTM sales:
2.86x
EV / EBIT:
11.86x
EV / Revenue:
2.95x
PEG ratio (5yr expected):
1.01x
EV / Free cash flow:
13.91x
Price / Operating cash flow:
13.48x
Enterprise value / EBITDA:
8.46x
Gross Profit (TTM):
$28.3B
Return On Assets:
7.11%
Net Income Margin (TTM):
15.71%
Return On Equity:
12.45%
Return On Invested Capital:
9.89%
Operating Margin:
15.95%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Income Statement | ||||||
| Revenue | $45.3B | $44.6B | $43.2B | $10.9B | $12.2B | |
| Gross Profit | $28.5B | $27.4B | $28.3B | $7.7B | $8.8B | |
| Operating Income | $10.2B | $9.3B | $10.8B | $1.9B | $1.9B | |
| EBITDA | $13.9B | $13.9B | $15.1B | $2B | $2.1B | |
| Diluted EPS | $3.57 | $1.81 | $4.01 | $0.48 | $1.83 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $35.2B | $29.9B | $32.9B | $32.2B | $43.4B | |
| Total Assets | $133.7B | $127.3B | $136.2B | $139.1B | $146.5B | |
| Current Liabilities | $22.8B | $23.1B | $26.9B | $32.2B | $34.1B | |
| Total Liabilities | $58.3B | $52.8B | $57B | $60.8B | $64.1B | |
| Total Equity | $75.4B | $74.5B | $79.3B | $78.2B | $82.4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $10.3B | $8.8B | $12.2B | $1.4B | $1.8B | |
| Cash From Investing | -$3.8B | -$7.1B | $8.4B | -$3.3B | $10.7B | |
| Cash From Financing | -$5.4B | -$3B | -$11.2B | -$729.7M | -$4.5B | |
| Free Cash Flow | $8B | $4.5B | $9.2B | -$506.9M | $218.7M | |
SNY
Sector
Market Cap
$121.2B
$28.4M
Price % of 52-Week High
82.66%
50.35%
Dividend Yield
4.42%
0%
Shareholder Yield
8.08%
-1.32%
1-Year Price Total Return
3.16%
-22.19%
Beta (5-Year)
0.446
0.521
Dividend yield:
4.42%
Annualized payout:
$2.04
Payout ratio:
-76.86%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$49.81
200-day SMA
Sell
Level
$50.76
Bollinger Bands (100)
Buy
Level
47.39 - 50.69
Chaikin Money Flow
Buy
Level
456M
20-day SMA
Sell
Level
$50.31
Relative Strength Index (RSI14)
Sell
Level
47.16
ADX Line
Sell
Level
11.18
Williams %R
Neutral
Level
-75.6962
50-day SMA
Buy
Level
$49.67
MACD (12, 26)
Sell
Level
-0.05
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
85.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.5827)
Buy
CA Score
(Annual)
Level (0.3829)
Buy
Beneish M-Score
(Annual)
Level (-2.7687)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-2.3171)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.
Stock Forecast FAQ
In the current month, SNY has received 5 Buy ratings 2 Hold ratings, and 0 Sell ratings. The SNY average analyst price target in the past 3 months is $60.13.
-
Where Will Sanofi Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sanofi share price will rise to $60.13 per share over the next 12 months.
-
What Do Analysts Say About Sanofi?
Analysts are divided on their view about Sanofi share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sanofi is a Sell and believe this share price will drop from its current level to $56.00.
-
What Is Sanofi's Price Target?
The price target for Sanofi over the next 1-year time period is forecast to be $60.13 according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is SNY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sanofi is a Buy. 5 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SNY?
You can purchase shares of Sanofi via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sanofi shares.
-
What Is The Sanofi Share Price Today?
Sanofi was last trading at $48.89 per share. This represents the most recent stock quote for Sanofi. Yesterday, Sanofi closed at $49.69 per share.
-
How To Buy Sanofi Stock Online?
In order to purchase Sanofi stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get SNY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SNY
Sector
P/E ratio
12.41x
23.66x
PEG ratio
1.01x
-0.01x
P/B ratio
1.76x
1.84x
Price / LTM sales
2.86x
1.60x
Growth Metrics
SNY
Sector
Revenue growth
11.24%
4.85%
Earnings growth
281.16%
11.15%
Revenue (5-year growth)
1.91%
6.45%
Earnings forecast
$1.57
-$0.20
Profitability
SNY
Sector
Profitability FY 2024
$28.1B
$3.6M
Return on invested capital
9.89%
-30.98%
Return on assets
7.11%
-27.62%
Return on equity
12.45%
-36.69%
Earnings Date
Last Earnings Date
Oct
24
Next Earnings Date
Jan
29
Estimated Next Earnings Date
Jan
23
Balance Sheet
SNY
Sector
Total cash
$18B
$27.2M
Short term investments
$505.7M
$25.7M
Total assets
$137.5B
$79.9M
Long term debt
--
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
65
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
